Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2025-12-24 @ 9:14 PM
NCT ID:
NCT02136004
Eligibility Criteria:
Inclusion Criteria:
Pre-Op Inclusion Criteria:
1 - Acceptable candidates for an elective, non-emergent diagnostic or interventional endovascular procedure via the common femoral artery using a 5, 6, or 7 Fr introducer sheath.
\-
Exclusion Criteria:
Pre-Operative Exclusion Criteria:
1. \- Significant bleeding diatheses or coagulopathy
2. \- Planned endovascular or surgical procedures within next 30 days
3. \- Planned ipsilateral femoral arteriotomy within next 90 days
4. \- Arteriotomy in ipsilateral groin within the past 30 days with any residual hematoma, significant bruising or vascular complication
5. \- Previous vessel closure device used in ipsilateral groin within the past 90 days
6. \- Previous vascular surgery or repair in the vicinity of the target access site
7. \- Severe peripheral vascular disease in the ipsilateral limb requiring surgical or endovascular treatment within the pervious 30 days or next 30 days
8. \- Existing nerve damage in ipsilateral limb
9. \- Extreme morbid obesity (BMI \> 4 kg/m2)
Intra-operative Exclusion Criteria:
10. \- Use of a procedural sheath that is \< 5 Fr or \> 7 Fr
11. \- Difficult insertion of procedural sheath or needle stick problems at the onset of the procedure
12. \- Placement of an ipsilateral venous sheath for procedure
13. \- Procedural sheath placement either through the superficial femoral artery and into the profunda femoris artery, or placement at or distal to bifurcation of the superficial femoral artery and the profunda femoris artery
14. \- In subjects receiving unfractionated heparin, an ACT \> 350 seconds, or \> 250 seconds in the presence of a GP IIb/IIIa inhibitor
15. \- Procedures or existing medical conditions that may extend index hospitalization beyond 24 hours post-procedure
16. \- Systemic hypertension (SBP \> 180 mmHg) or hypotension (SBP \< 90 mmHg) just prior to enrollment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02136004
Study Brief:
Protocol Section:
NCT02136004